Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Accounts Payables (2020 - 2024)

Intelligent Bio Solutions has reported Accounts Payables over the past 5 years, most recently at $2.1 million for Q1 2024.

  • Quarterly results put Accounts Payables at $2.1 million for Q1 2024, up 33.14% from a year ago — trailing twelve months through Mar 2024 was $2.1 million (up 33.14% YoY), and the annual figure for FY2023 was $2.6 million, up 60.61%.
  • Accounts Payables for Q1 2024 was $2.1 million at Intelligent Bio Solutions, up from $1.8 million in the prior quarter.
  • Over the last five years, Accounts Payables for INBS hit a ceiling of $3.6 million in Q3 2023 and a floor of $448886.0 in Q4 2021.
  • Median Accounts Payables over the past 5 years was $1.5 million (2021), compared with a mean of $1.5 million.
  • Peak annual rise in Accounts Payables hit 313.35% in 2022, while the deepest fall reached 41.9% in 2022.
  • Intelligent Bio Solutions' Accounts Payables stood at $734825.0 in 2020, then plummeted by 38.91% to $448886.0 in 2021, then soared by 313.35% to $1.9 million in 2022, then dropped by 4.98% to $1.8 million in 2023, then grew by 20.75% to $2.1 million in 2024.
  • The last three reported values for Accounts Payables were $2.1 million (Q1 2024), $1.8 million (Q4 2023), and $3.6 million (Q3 2023) per Business Quant data.